Literature DB >> 26943401

Simultaneous pulmonary metastases from colon and prostate cancer to the same lobe.

Toru Nakamura1, Tomonari Oki2, Yoshiro Otsuki3, Tatsuaki Yoneda4, Yasuyuki Kobayashi5, Kazuhito Funai6, Futoru Toyoda7.   

Abstract

Simultaneous pulmonary metastases from different primary tumors to the same lobe are extremely rare, and we herein report the case. Surgical specimen of the pulmonary metastasis from colon cancer contained two additional nodules that were confirmed as metastases from prostate cancer. Pulmonary metastasis from prostate cancer rarely forms nodules, and there is a discrepancy in the incidence of pulmonary metastases between autopsy and clinical findings. This case suggests that different malignant tumors could simultaneously metastasize to the same pulmonary lobe, and more pulmonary metastases from prostate cancer might exist than expected.

Entities:  

Keywords:  Colon cancer; Prostate cancer; Pulmonary metastases

Year:  2015        PMID: 26943401      PMCID: PMC4747968          DOI: 10.1186/s40792-015-0035-3

Source DB:  PubMed          Journal:  Surg Case Rep        ISSN: 2198-7793


Background

Pulmonary metastasectomy plays an important role in selected patients and is widely performed, especially in colorectal cancer patients. However, simultaneous pulmonary metastasis from another primary organ is very rare. We experienced a case of simultaneous metastases from colon and prostate cancer and herein report the case.

Case presentation

A 76-year-old man showed a solitary lung nodule on computed tomography (CT) (Figure 1A) 5 years after Hartmann colostomy for a perforated T3N0 colon cancer. He had undergone liver metastasectomy from colon cancer 1 year prior. Positron emission tomography/CT revealed intense uptake not only in the lung nodule but also in the prostate with standardized uptake value of 4.8 and 11.5, respectively (Figure 2). Serum prostate-specific antigen (PSA) level was elevated (98.84 ng/ml). Prostate biopsy confirmed adenocarcinoma of the prostate with a Gleason score of 8 (4 + 4), and antiandrogen therapy was administered. Thereafter, as it was suspected that the lung nodule was metastasis from colon cancer, he underwent left upper lobectomy with hilar lymph node dissection. Resected specimen revealed a circumscribed nodule in the hilum and two additional tiny nodules in the subpleural space. Histopathological examination of the hilar lesion revealed a well-differentiated adenocarcinoma, immunohistochemically proven to be metastasis from colon cancer based on negative staining for Cytokeratin 7 and positive staining for Cytokeratin 20 (Figure 3A,B,C); it was also shown that the subpleural lesions were adenocarcinoma, proven to be metastases from prostate cancer based on positive staining for PSA (Figure 3D,E). There was no lymph node metastasis.
Figure 1

Computed tomography. (A) Computed tomography demonstrated a pulmonary nodule (23 mm in diameter) in the left hilum. (B) Two nodules in the subpleural space (7 and 9 mm in diameter, respectively) were also shown, but not identified before surgery (arrowheads).

Figure 2

Positron emission tomography/computed tomography demonstrated intense uptakes both in the left hilum and prostate.

Figure 3

Hilar nodule and tumor cells. (A) A hilar nodule showing well-differentiated adenocarcinoma (hematoxlyin and eosin [H & E], ×75). (B) Immunohistochemically, tumor cells in the hilum were negative for Cytokeratin 7. (CK7, ×150). (C) Tumor cells in the hilum were positive for Cytokeratin 20 and consistent with metastasis from colon cancer. (CK20, ×150). (D) Subpleural nodule also showing adenocarcinoma. (H & E, ×150). (E) Tumor cells in the subpleural nodule were positive for prostate-specific antigen and confirmed as metastasis from prostate cancer (PSA, ×150).

Computed tomography. (A) Computed tomography demonstrated a pulmonary nodule (23 mm in diameter) in the left hilum. (B) Two nodules in the subpleural space (7 and 9 mm in diameter, respectively) were also shown, but not identified before surgery (arrowheads). Positron emission tomography/computed tomography demonstrated intense uptakes both in the left hilum and prostate. Hilar nodule and tumor cells. (A) A hilar nodule showing well-differentiated adenocarcinoma (hematoxlyin and eosin [H & E], ×75). (B) Immunohistochemically, tumor cells in the hilum were negative for Cytokeratin 7. (CK7, ×150). (C) Tumor cells in the hilum were positive for Cytokeratin 20 and consistent with metastasis from colon cancer. (CK20, ×150). (D) Subpleural nodule also showing adenocarcinoma. (H & E, ×150). (E) Tumor cells in the subpleural nodule were positive for prostate-specific antigen and confirmed as metastasis from prostate cancer (PSA, ×150). Antiandrogen therapy was continued without any cytotoxic therapy for colon cancer. He died of acute cardiac failure 2 years after pulmonary lobectomy with undetectable serum PSA level (<0.1 ng/ml). Autopsy imaging showed no sign of recurrence.

Discussion

The present case revealed simultaneous pulmonary metastases from colon and prostate cancer in the same lobe. Although a case of primary lung cancer with metastatic lymph node from prostate cancer has been reported, simultaneous pulmonary metastases from colorectal and prostate cancer are uncommon [1]. Surgical resection of a metastatic lung tumor is a feasible treatment option, especially in colorectal cancer patients. In contrast, the clinical significance of pulmonary metastasectomy in prostate cancer has not been established. This is because most pulmonary metastases from prostate cancer reveal lymphangitic spread, not nodules as in the present case, and are usually concomitant with bone metastases. While bone metastasis is the most frequent dissemination and a prognostic factor in prostate cancer, pulmonary metastasis is less frequent and has no impact on survival because of high sensitivity to endocrine therapy [2,3]. Because of these findings, clinical significance of pulmonary metastasectomy from prostate cancer is not established [4]. Although pulmonary metastases from prostate cancer account for 23% to 63% in autopsy series [2,5-7], only 3.6% to 21.2% of them are clinically evident [3,8,9]. These data suggest that more pulmonary metastases from prostate cancer might exist than expected and tend to be overlooked clinically. In the present case, the metastases were overlooked before surgery, in spite of the visualization on CT retrospectively (Figure 1B).

Conclusions

To the best of our knowledge, this is the first report that simultaneous pulmonary metastases from colon and prostate cancer occurs to the same lobe. Thoracic surgeons should be aware of this rare condition and that more pulmonary metastases from prostate cancer might exist than expected.

Consent

We routinely obtained general consent from every patient for using their clinical data before surgery. Written informed consent was not obtained from the patient for publication of this case report because this report is just a retrospective case report without additional invasive examinations or treatments for the study.
  9 in total

1.  Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

Authors:  L Bubendorf; A Schöpfer; U Wagner; G Sauter; H Moch; N Willi; T C Gasser; M J Mihatsch
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

2.  PULMONARY METASTASES FROM CARCINOMA OF THE PROSTATE: INCIDENCE AND CASE REPORT OF A LONG REMISSION.

Authors:  B H BOLTON
Journal:  J Urol       Date:  1965-07       Impact factor: 7.450

3.  Peribronchial lymph node metastasis from prostate cancer in pulmonary lobectomy for primary lung adenocarcinomas: a possible source of pitfall with therapeutic consequences.

Authors:  Giulio Rossi; Nazarena Nannini; Christian Casali; Lucia Longo; Maria C Mengoli; Alberto Cavazza
Journal:  Histopathology       Date:  2011-05       Impact factor: 5.087

4.  Lung metastases in prostatic carcinoma. Clinical significance.

Authors:  M J Varkarakis; A R Winterberger; J Gaeta; R H Moore; G P Murphy
Journal:  Urology       Date:  1974-04       Impact factor: 2.649

5.  Roentgenologic features of pulmonary carcinomatosis from carcinoma of the prostate.

Authors:  D A Legge; C A Good; J Ludwig
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1971-02

6.  The role of resection of pulmonary metastases from prostate cancer: a case report and literature review.

Authors:  Christopher J D Wallis; John C English; S Larry Goldenberg
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

7.  Clinical significance of pulmonary metastases in stage D2 prostate cancer patients.

Authors:  H Nakamachi; H Suzuki; K Akakura; T Imamoto; T Ueda; M Ishihara; Y Furuya; T Ichikawa; T Igarashi; H Ito
Journal:  Prostate Cancer Prostatic Dis       Date:  2002       Impact factor: 5.554

8.  Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved.

Authors:  H Saitoh; M Hida; T Shimbo; K Nakamura; J Yamagata; T Satoh
Journal:  Cancer       Date:  1984-12-15       Impact factor: 6.860

9.  Pulmonary metastases from prostate cancer.

Authors:  S J Fabozzi; P F Schellhammer; A M el-Mahdi
Journal:  Cancer       Date:  1995-06-01       Impact factor: 6.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.